Sexual Dysfunction

"I think it's really important when we're prescribing any medication to our patients to really have a good idea of what they can expect," says Evan Panken, MD.

"I think that using this database does allow for some generalizability, and we're pretty confident in that," says Evan Panken, MD.

There were no differences in the number of treatment-related TEAEs in patients who received sildenafil cream vs patients who received placebo.

"We hypothesize that when we treat female sexual dysfunction, we can ultimately improve the dynamics between the couple, and therefore improve the male partner satisfaction with his IPP," says Thairo Pereira, MD.

“In addition, the average levels of the medication in the bloodstream, at least during the first 30 minutes, was higher,” says Steven A. Kaplan, MD.

“So, the concept behind delivering something orally in a spray is to hopefully avoid the whole GI effect and get faster absorption,” says Steven A. Kaplan, MD.

"I'm very transparent with my patients by telling them these exist. I don't provide them because we don't have enough level of evidence or body of research supporting them," says Ramy Abou Ghayda, MD, MPH, MBA.

Aspargo plans to file a new drug application with the FDA to support regulatory approval of ASP-001 for erectile dysfunction in the United States.

"For [men] to come to the practice and talk about [a sensitive issue] is a big step," says Adity Dutta, MSN, AGACNP-BC.

"While our results may imply that a strict all-business professionalism is superior, I think it's important to acknowledge that humor is really subjective," says Max D. Sandler.

“Across the whole survey, an average of 66% preferred the professional card. The highest rate of selection of the humorous card in a single question was only 38.4%,” says Max D. Sandler.

Data showed a 90.6% rate of correct consumer self-selection among those who used the Web App Technology with the DFL vs 57.3% among those that used the DFL alone.

"But both groups reported that Peyronie's disease does impact their mental health, and a large portion of both groups also said that they had had a negative experience with a urologist at some point," says Olivia Paulsen.

"If they have some issues with dexterity, if I feel they're not going to be able to pump the device up adequately, or they don't have a partner that can do it, they're probably not a good candidate for an inflatable device," says Charles Kaplan, MD.

"I feel like there's still a lot of lack of knowledge about the more advanced treatments for men's health; specifically, penile implants," says Charles Kaplan, MD.

"I think all the major implant companies are constantly improving the devices," says Hossein Sadeghi-Nejad, MD, FACS.

"When they said that they value privacy over cost and convenience, I think that is the clearest sign that the stigma for men's health still exists," says Justin M. Dubin, MD.

“What was also interesting in our study was that when choosing a source of medications, we asked them, what made you decide to go with that option? And 62% of men said that they valued privacy above everything,” says Justin M. Dubin, MD.

A novel co-formulation of bremelanotide and a PDE5 inhibitor allows the treatment to be administered to patients via a single injection.

“However, what direct to consumer does provide is convenience and privacy. Men's health has a huge stigma on it,” says Justin M. Dubin, MD.

"I would say the biggest take-home is that for Hispanic patients, there's a reduced likelihood of a successful fertility outcome that has been observed in an area that is enriched with a Hispanic population that's comparable to that of the US," says Devon M. Langston, MD.

"When controlling for demographic and clinical factors, the number of live births was reduced for Hispanic men," says Devon M. Langston, MD.

"Questions that arise for us [include] why, and what's further contributing to our observed outcome?" says Devon M. Langston, MD.

"When we reviewed the data, we noticed a large difference in outcomes based on ethnicity," says Devon M. Langston, MD.

Petros also announced that it has received positive feedback from the FDA after the agency’s informal review of Petros’ technology component for self-selection.

"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.

“We don't have the sex therapists or psychologists who specialize in sexual dysfunction here... It's incredibly important, because if it doesn't start out as psychological, certainly, it becomes psychological, at least in some measure,” says Thomas M. Jaffe, MD.

"in general, we can use a simpler regimen [of testosterone replacement therapy] and achieve normal levels," says Peter N. Tsambarlis, MD.

"When we think about medical fertility preservation, it really is an all-hands-on-deck type of situation," says Kristin Smith, MD.